The cancer killing effects of chemotherapy could be synergised by injecting vitamin C as concluded in the latest study published in the Science Transnational Medicine. The use of vitamin C will be of great values as it is safe, effective and cost-effective.
Pharmaceutical companies are hesitating to initiate clinical trials to confirm anti-cancer effects of vitamin C as vitamins cannot be patented. It was reported by researchers that vitamin C’ catastrophe is only limited to cancerous cells after absorption. This was revealed when researchers injected vitamin C in patients suffering from ovarian cancer and found significant improvement. Minor side effects were also observed in certain enrolled patients.
“Patients are looking for safe and low-cost choices in their management of cancer,” she told BBC News. “Intravenous vitamin C has that potential based on our basic science research and early clinical data.”
“Because vitamin C has no patent potential, its development will not be supported by pharmaceutical companies,” said lead researcher Qi Chen.
“We believe that the time has arrived for research agencies to vigorously support thoughtful and meticulous clinical trials with intravenous vitamin C.”
“Any potential treatment for cancer needs to be thoroughly evaluated in large clinical trials to make sure it’s safe and effective, so further studies are needed before we know for sure what benefits high dose vitamin C may have for patients.”
Reference: Yan Ma, Julia Chapman, Mark Levine, Kishore Polireddy, Jeanne Drisko, Qi Chen. High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy. (2014). Sci. Transl. Med. DOI: 10.1126/scitranslmed.3007154
Copyright 2012 Medimoon.com. All rights reserved. No part of this site can be reproduced without our written permission.